Navigation Links
Plant stem cells could be fruitful source of low-cost cancer drug
Date:10/25/2010

A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.

Researchers have isolated and grown stem cells from a yew tree whose bark is a natural source of the anticancer compound paclitaxel. The development could enable the compound to be produced on a commercial scale at low cost, with no harmful by-products.

Scientists and engineers behind the development say the drug treatment currently used on lung, ovarian, breast, head and neck cancer could become cheaper and more widely available. The study was carried out by the University of Edinburgh and the Unhwa Biotech company in Korea.

Currently, an extract from yew tree bark is used to industrially manufacture the compound paclitaxel. However, this process is expensive, requires supplies of mature trees, and creates environmentally damaging by-products.

Researchers claim that using stem cells self-renewing tree cells which can be manipulated to produce large amounts of the active compound would effectively create an abundant supply of the drug. The process would cost far less than conventional methods.

Scientists behind the project have also cultured stem cells from other plants with medical applications, indicating that the technique could be used to manufacture other important pharmaceuticals besides paclitaxel.

The study was published in Nature Biotechnology and supported by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council.

Professor Gary Loake, of the University of Edinburgh's School of Biological Sciences, who led/took part in the study, said: "Plants are a rich source of medicine around one in four drugs in use today is derived from plants. Our findings could deliver a low-cost, clean and safe way to harness the healing power of plants, potentially helping to treat cancer, and other conditions."


'/>"/>

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh
Source:Eurekalert

Related medicine news :

1. Studies show everolimus-eluting stent implantation reduces restenosis and repeat revasculariztion
2. Vitamin D deficiency linked to lung transplant rejection
3. OHSU research suggests compound administered during some bone marrow transplants elevates risks
4. Kings College London reveals promising techniques for extending the life of an organ transplant
5. Southampton to conduct UKs first cochlear implant operation to give sound in both ears
6. Biosynthetic Corneas Show Promise in Transplants
7. Decade-long trial confirms benefts of steroid withdrawal for transplant patients
8. Hispanics and Asians less likely to receive liver transplants
9. Study identifies factors which predict alcohol use after liver transplantation
10. Chronic health conditions common for stem cell transplant survivors
11. Plant compound resveratrol shown to suppresses inflammation, free radicals in humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable ... Solsken Line of Model Homes . Independently, Ecocor and RPA have extensive experience ...
(Date:9/22/2017)... ... September 22, 2017 , ... Pullano Law Offices, a ... L. Pullano has been selected to serve as President of the North Suburban ... the Installation and Award Dinner hosted by the NSBA at the North Shore Country ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... help you brush more effectively even on the go. Their electric toothbrushes aggressively ... and gum inflammation, with UV sanitizing technology. Combining leading edge Enke technology with ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... Lyme and other tick-borne diseases through research, education and awareness, today announced the ... A noted immunologist and microbiologist, Dr. Sellati has more than 20 years of ...
(Date:9/21/2017)... ... 21, 2017 , ... The American Addiction Treatment Association (AATA) ... in the addiction treatment industry entitled: Special Investigations Unit (SIU) – What ... state and federal governments are increasingly scrutinizing the addiction treatment industry for fraudulent ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Medical ... knowledge and skills while treating their patients. ... hands-on experience without involving patients. Simulation provides ... Clinicians can carry out procedures, refine techniques ... risk. Integration of new technology, such as ...
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical stage ... Ideation and Behavior (ASIB), has been granted Fast Track status ... therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + ... pivotal trial of this sequential therapy targeting patients who are ... ...
(Date:9/5/2017)... , Sept. 5, 2017 Sapheneia and ... DoseCheck solution. Scannerside DoseCheck is a third-party Vendor neutral ... CT scanners and allows compliance with current MITA standards. ... proprietary XR 29 DoseCheck solution is specifically designed to ... alerts of potential radiation doses over a predefined threshold. ...
Breaking Medicine Technology: